angiogenesis inhibitors (ElexoPharm/VU University Medical Center)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameangiogenesis inhibitors (ElexoPharm/VU University Medical Center)
Drug Alias Nametumor vessel targeting program (ElexoPharm)angiogenesis inhibitors (ElexoPharm)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElexoPharm Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElexoPharm GmbhVu University Medical Center
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A